The significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.

[1]  J. Claflin,et al.  Genetics of the phosphocholine-specific antibody response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected. , 1988, Journal of immunology.

[2]  N. Chiorazzi,et al.  Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia , 1989, The Journal of experimental medicine.

[3]  L. Arnold,et al.  Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline , 1989, The Journal of experimental medicine.

[4]  J. Binet,et al.  Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. , 1990 .

[5]  P. Kirkham,et al.  Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. , 1992, The EMBO journal.

[6]  P. Casali,et al.  Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. , 1993, Autoimmunity.

[7]  G. Dighiero,et al.  The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. , 1994, Immunology today.

[8]  A. Coutinho,et al.  Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Chiorazzi,et al.  Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells , 1995, The Journal of experimental medicine.

[10]  N. Chiorazzi,et al.  Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. , 1996, Blood.

[11]  L. Rassenti,et al.  Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. , 1997, Journal of immunology.

[12]  J. C. Almagro,et al.  Evolution of the structural repertoire of the human V(H) and Vkappa germline genes. , 1997, International immunology.

[13]  L A Herzenberg,et al.  Frequent occurrence of identical heavy and light chain Ig rearrangements. , 1997, International immunology.

[14]  E. Söderlind,et al.  Exploiting sequence space: shuffling in vivo formed complementarity determining regions into a master framework. , 1998, Gene.

[15]  L. Rassenti,et al.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.

[16]  L. Herzenberg,et al.  Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Seidl,et al.  Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[19]  G. Silverman,et al.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.

[20]  C. Janeway,et al.  The Immune System in Health and Disease , 2001 .

[21]  M. Radic,et al.  Editors and editing of anti-DNA receptors. , 2001, Immunity.

[22]  Gérard Lefranc,et al.  The Immunoglobulin FactsBook , 2001 .

[23]  B. Sutton,et al.  Evidence for Involvement of a Hydrophobic Patch in Framework Region 1 of Human V4-34-Encoded Igs in Recognition of the Red Blood Cell I Antigen1 , 2002, The Journal of Immunology.

[24]  Göran Roos,et al.  Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. , 2002, Blood.

[25]  Xiao-Jie Yan,et al.  B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. , 2002, Blood.

[26]  Hongsheng Wang,et al.  Evidence for a Ligand-Mediated Positive Selection Signal in Differentiation to a Mature B Cell 1 , 2003, The Journal of Immunology.

[27]  Y. Jang,et al.  Anti-DNA antibodies: aspects of structure and pathogenicity , 2003, Cellular and Molecular Life Sciences CMLS.

[28]  M. Schlissel,et al.  Regulating antigen-receptor gene assembly , 2003, Nature Reviews Immunology.

[29]  G. Juliusson,et al.  Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. , 2003, Blood.

[30]  Hongsheng Wang,et al.  Positive selection focuses the VH12 B‐cell repertoire towards a single B1 specificity with survival function , 2004, Immunological reviews.

[31]  J. Gribben,et al.  Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. , 2004, Blood.

[32]  Steven L. Allen,et al.  Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia , 2004, The Journal of experimental medicine.

[33]  Anna Tramontano,et al.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. , 2004, The Journal of clinical investigation.

[34]  E. Milner,et al.  Human innate B cells: a link between host defense and autoimmunity? , 2005, Springer Seminars in Immunopathology.

[35]  Göran Roos,et al.  Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. , 2004, Blood.

[36]  L. Herzenberg,et al.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion , 2005, Springer Seminars in Immunopathology.

[37]  Nikolaos Laoutaris,et al.  Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. , 2005, Blood.

[38]  E. Meffre,et al.  Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. , 2005, The Journal of clinical investigation.

[39]  K. Stamatopoulos,et al.  Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. , 2004, Blood.

[40]  N. Maizels.  Immunoglobulin gene diversification. , 2005, Annual review of genetics.

[41]  D. Schatz,et al.  Biochemistry of V(D)J recombination. , 2005, Current topics in microbiology and immunology.

[42]  R. Hardy.  B-1 B Cell Development1 , 2006, The Journal of Immunology.

[43]  E. Meffre,et al.  B-Cell Chronic Lymphocytic Leukemia (B-CLL) Cells Express Antibodies Reactive with Antigenic Epitopes Expressed on the Surface of Common Bacteria. , 2006 .

[44]  G. Packham,et al.  Structural and Functional Features of the B-Cell Receptor in IgG-Positive Chronic Lymphocytic Leukemia , 2006, Clinical Cancer Research.

[45]  C. Croce,et al.  B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[46]  H. Döhner,et al.  Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. , 2005, Blood.

[47]  D. Rawlings,et al.  B cell–intrinsic TLR signals amplify but are not required for humoral immunity , 2007, The Journal of experimental medicine.

[48]  Nikolaos Laoutaris,et al.  Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. , 2006, Blood.

[49]  M. Catherwood,et al.  VH3–48 and VH3–53, as well as VH3–21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis , 2007 .

[50]  N. Caporaso,et al.  Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. , 2007, Blood.

[51]  Xiao-Jie Yan,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2005 .

[52]  M. Stratton,et al.  Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing , 2008, Proceedings of the National Academy of Sciences.

[53]  Nikolaos Laoutaris,et al.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. , 2007, Blood.

[54]  B. Diamond,et al.  Pathogenic Autoantibodies in Systemic Lupus Erythematosus Are Derived from Both Self-Reactive and Non-Self-Reactive B Cells , 2008, Molecular medicine.

[55]  E. Meffre,et al.  Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation , 2008, Molecular medicine.

[56]  R. Rosenquist,et al.  A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. , 2008, Blood.

[57]  Francesco Bertoni,et al.  Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome , 2009, Clinical Cancer Research.

[58]  K. Stamatopoulos,et al.  Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors , 2009, Leukemia.

[59]  K. Stamatopoulos,et al.  Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. , 2009, Blood.

[60]  D. V. van Gent,et al.  A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen. , 2009, Blood.

[61]  K. Stamatopoulos,et al.  Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. , 2008, Blood.

[62]  D. Rossi,et al.  Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study , 2009, British journal of haematology.

[63]  D. Catovsky,et al.  Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation , 2010, Haematologica.

[64]  K. Stamatopoulos,et al.  A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence , 2010, Leukemia.

[65]  K. Stamatopoulos,et al.  Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution , 2010, Leukemia.

[66]  G. Simonetti,et al.  A novel Rag2-/-gammac-/--xenograft model of human CLL. , 2010, Blood.

[67]  N. Chiorazzi,et al.  Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. , 2010, Blood.

[68]  M. Nicoloso,et al.  Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological Features , 2010, Clinical Cancer Research.

[69]  G. Marti,et al.  The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia , 2010, Cytometry. Part B, Clinical cytometry.

[70]  Ron Diskin,et al.  Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.

[71]  D. Schatz,et al.  V(D)J recombination: mechanisms of initiation. , 2011, Annual review of genetics.

[72]  P. Hillmen.  Using the biology of chronic lymphocytic leukemia to choose treatment. , 2011, Hematology. American Society of Hematology. Education Program.

[73]  N. Chiorazzi,et al.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. , 2011, Blood.

[74]  Stavroula Ntoufa,et al.  Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients , 2011, Haematologica.

[75]  Irene Puga,et al.  Innate control of B cell responses. , 2011, Trends in immunology.

[76]  P. Casali,et al.  Immunoglobulin class-switch DNA recombination: induction, targeting and beyond , 2012, Nature Reviews Immunology.

[77]  M. Minden,et al.  Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling , 2012, Nature.

[78]  Stavroula Ntoufa,et al.  Distinct Innate Immunity Pathways to Activation and Tolerance in Subgroups of Chronic Lymphocytic Leukemia with Distinct Immunoglobulin Receptors , 2012, Molecular medicine.

[79]  M. Shlomchik,et al.  Germinal center selection and the development of memory B and plasma cells , 2012, Immunological reviews.

[80]  U. Klein,et al.  Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. , 2012, Blood.

[81]  Kostas Stamatopoulos,et al.  Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. , 2012, Blood.